Breaking the Cycle of Overeating: Lessons from Mr. Greedy

When patients ask about our Weight Support Clinic at Scout Moor Pharmacy, Edenfield, Bury, I often hear a similar back story involving yo-yo diets, emotional eating and negative perceptions of body image.  There is a lot of judgement involved- “I just don’t have the willpower”, I hear.  What patients don’t often realise is that- actually- obesity is now classed as an inflammatory disease involving complex biological interactions between the brain, hormones and internal organs and tissues which control eating and our response to food.  I have a PhD in glucose metabolism in cancer and spent many years researching how sugar and fats are controlled in disease as a university academic.  However, despite reading hundreds of research articles on the subject, it was while reading Mr Greedy to my children that I came across probably the best explanation for the biological control of appetite and weight gain I’d ever seen.

Mr Greedy liked to eat!
In fact Mr Greedy loved to eat, and the more
he ate the fatter he became.
And the trouble was the fatter he became the
more hungry be became.
And the more hungry he became the more he
ate.
And the more he ate the fatter he became.
And so it went on.

In this classic children’s book by Roger Hargreaves, the title character finds himself trapped in an endless cycle of overeating.

This simple yet profound passage illustrates a very real problem faced by many people today: the cycle of overeating and weight gain that can seem impossible to break. The more you eat, the hungrier you feel, and the more you crave food. It’s a vicious loop that’s not just about willpower; it’s driven by complex biological processes. Luckily, modern medicine is starting to offer solutions, one of which is GLP-1 analogues, a class of medications that target the very biological pathways responsible for hunger and appetite regulation.

The Cycle of Hunger and Overeating: What’s Happening in the Body?

Mr. Greedy’s cycle—eating more, gaining weight, feeling hungrier, and eating more—reflects a challenge many people face in terms of appetite regulation. The relationship between food intake and hunger is controlled by several biological systems, most importantly the brain, the gut, and various hormones. Here’s how it works:

• Hunger Signals: When we’re hungry, a hormone called ghrelin is released, signaling to the brain that it’s time to eat. Ghrelin levels rise before meals and drop after eating.
• Satiety Signals: After eating, the body releases hormones like leptin (which helps us feel full) and insulin (which helps regulate blood sugar and tells the body it’s time to stop eating). However, in people with obesity or metabolic disorders, these signals can become less effective, leading to overeating and persistent hunger.
• The Role of GLP-1: One of the most important hormones for regulating both hunger and food intake is glucagon-like peptide-1 (GLP-1). GLP-1 is released from the intestines after eating, and it helps with insulin release, slows gastric emptying, and signals to the brain to reduce appetite. However, in individuals with obesity, the body may not respond properly to GLP-1, or the levels of GLP-1 may not be high enough to curb appetite effectively.

This disruption in appetite regulation is what leads to the cycle Mr. Greedy experiences: the more he eats, the more his body demands food, and the hungrier he becomes. In reality, when appetite regulation goes awry, it becomes incredibly hard to control food intake, just like Mr. Greedy’s insatiable hunger.

How GLP-1 Analogues Break the Cycle of Overeating

This is where GLP-1 analogues—drugs that mimic the action of natural GLP-1—can make a difference. GLP-1 analogues such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) work by activating the GLP-1 receptors in the brain and digestive system, helping to regulate hunger and promote satiety. However, tirzepatide is especially notable for its double-action, as it not only activates GLP-1 receptors but also acts on a second hormone receptor, GIP (gastric inhibitory polypeptide). This dual effect helps to further suppress appetite, improve insulin sensitivity, and increase feelings of fullness, making it a powerful tool in weight management.

Here’s how these GLP-1 analogues help break the cycle of overeating:

1. Reducing Hunger: GLP-1 analogues signal to the brain that you’re full, reducing the hunger signals that would normally drive you to eat more. Just like how GLP-1 works in the body naturally, these medications help mimic that effect, effectively curbing the urge to snack or overeat.
2. Slowing Gastric Emptying: By slowing the emptying of the stomach, GLP-1 analogues help food stay in the stomach longer, making you feel fuller for a longer period of time after meals. This helps combat the sensation of hunger that often drives overeating, similar to how Mr. Greedy might have benefited from a delayed feeling of fullness that could have stopped him from reaching for that next bite.
3. Controlling Blood Sugar: GLP-1 analogues also help stabilize blood sugar levels by promoting insulin release when glucose is present in the bloodstream, preventing the post-meal spikes and dips in blood sugar that can trigger hunger and cravings.
4. Breaking the Feedback Loop: By reducing hunger and promoting satiety, GLP-1 analogues help break the negative feedback loop of eating more, gaining weight, and feeling hungrier. Instead of being caught in an endless cycle like Mr. Greedy, people using GLP-1 analogues can regain control of their appetite and make healthier choices around food.

Real-World Results: GLP-1 Analogues and Weight Loss

For individuals who struggle with obesity or have difficulty controlling their appetite, GLP-1 analogues can be a game-changer. Clinical studies have shown that these medications can lead to significant weight loss by reducing hunger and promoting healthier eating habits. In fact, semaglutide has been shown to help people lose an average of 15-20% of their body weight, and tirzepatide has demonstrated even greater results, with some individuals experiencing weight loss of 20% or more.

In this sense, GLP-1 analogues work by addressing one of the root causes of overeating: the body’s dysregulated hunger signals. By improving how the body responds to food intake, these medications help people regain control over their appetite and avoid the cycle of overeating that people like Mr. Greedy experience.

Breaking Free from Mr. Greedy’s Cycle

The cycle of overeating and constant hunger that Mr. Greedy experiences is a familiar one for many individuals, particularly those with obesity or metabolic disorders. The good news is that, just as Mr. Greedy could benefit from a little outside help to curb his cravings, modern medicine is now offering solutions that can help break the cycle. GLP-1 analogues, especially tirzepatide (Mounjaro), provide a way to reset the body’s appetite regulation system, making it easier for individuals to feel satisfied after meals and avoid the constant hunger that leads to overeating.

By addressing the biological factors that drive hunger and appetite, these medications offer a lifeline for people who have been stuck in the same loop of overeating, weight gain, and constant cravings. So, while Mr. Greedy might never have discovered GLP-1 analogues, those of us today struggling with similar issues now have a powerful tool to help break free from the cycle and achieve a healthier, more balanced relationship with food.